Could Airiver Medical’s ESSpand balloon reduce repeat procedures in chronic rhinosinusitis?
Find out how Airiver Medical’s ESSpand pivotal trial could reshape chronic rhinosinusitis care and sinus surgery outcomes.
Find out how Airiver Medical’s ESSpand pivotal trial could reshape chronic rhinosinusitis care and sinus surgery outcomes.
Airiver Medical wins FDA Breakthrough Device status for its pulmonary drug coated balloon. Discover what this means for airway stenosis treatment and clinical trials.